Predictions
Aldeyra Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.90
08.09.20
08.09.20
-
04.11.21
04.11.21
67.35%
15.07.21
15.07.21
Alligator Bioscience AB
Start price
Target price
Perf. (%)
€0.88
08.09.20
08.09.20
-
12.09.20
12.09.20
-3.41%
12.09.20
12.09.20
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.54
08.09.20
08.09.20
-
12.09.20
12.09.20
-5.70%
12.09.20
12.09.20
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.60
08.09.20
08.09.20
-
04.11.21
04.11.21
-13.99%
13.11.20
13.11.20
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€59.60
08.09.20
08.09.20
-
10.09.20
10.09.20
-0.47%
10.09.20
10.09.20
Tonix Pharmaceuticals Holding Corp.
Start price
Target price
Perf. (%)
€134.00
08.09.20
08.09.20
-
09.09.20
09.09.20
-2.24%
09.09.20
09.09.20
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€56.16
08.09.20
08.09.20
-
12.09.20
12.09.20
-18.91%
12.09.20
12.09.20
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€47.63
08.09.20
08.09.20
-
19.09.20
19.09.20
-4.25%
19.09.20
19.09.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.88
08.09.20
08.09.20
-
21.09.20
21.09.20
6.38%
21.09.20
21.09.20
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
08.09.20
08.09.20
-
04.11.21
04.11.21
59.76%
05.11.21
05.11.21
Hexo Corp.
Start price
Target price
Perf. (%)
€31.77
08.09.20
08.09.20
€56.00
04.11.21
04.11.21
-45.36%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Fair valuation
Top 10 in its market
Sorrento Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.60
08.09.20
08.09.20
€7.00
21.09.20
21.09.20
46.07%
21.09.20
21.09.20
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Inovio Pharma
Start price
Target price
Perf. (%)
€7.80
07.09.20
07.09.20
-
23.09.20
23.09.20
74.36%
23.09.20
23.09.20
Risky Investment